Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
2022年5月17日 - 6:47AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2022
Commission File Number: 001-40414
Skylight Health Group Inc.
(Translation of registrant’s name into English)
5520 Explorer Drive, Suite 402
Mississauga, Ontario L4W 5L1
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___
DOCUMENTS INCLUDED AS PART OF THIS REPORT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | |
| Skylight Health Group Inc. |
| (Registrant) |
| |
Date: May 16, 2022 | /s/ Andrew Elinesky |
| Andrew Elinesky |
| Chief Financial Officer |
Skylight Health (NASDAQ:SLHG)
過去 株価チャート
から 4 2024 まで 5 2024
Skylight Health (NASDAQ:SLHG)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Skylight Health Group Inc (ナスダック市場): 0 recent articles
その他のSkylight Health Group Inc.ニュース記事